The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.
This online resource provides a variety of tools to assist corrections staff and public health TB programs who work with correctional facilities in TB control efforts. These tools may be downloaded and modified to meet the specific needs of each site. The site contains a large compilation of modifiable forms and templates, archived webinar training, and various written, video and online resources to support TB work within correctional facilities.
This fact sheet provides general information on TB drug resistance.
This infographic provides general information on TB drug resistance.
This fact sheet presents general information on latent TB infection.
The website contains the history of World TB Day and multiple resources, including web graphics, that can be used in social media updates, websites, and presentations. This website also allows TB organizations to share their World TB Day 2016 activities.The 2016 US World TB Day theme is "End TB."
This tool is designed to help clinicians select adults for LTBI testing who are at high-risk for TB exposure or progression to TB disease. The tool calls out 3 groups for testing: foreign-born; immunosuppressed (e.g., HIV, TNF alpha inhibitor use, steroids, organ transplant); and contacts.
The Stop TB Partnership developed a set of free campaign materials for World TB Day 2016. Resources include posters, postcards, a toolkit, a t-shirt design, and cap and sarong designs. The resources come in six languages - Arabic, Chinese, English, French, Spanish, and Russian.
This document shares best practices in engagement of health care providers in programmatic management of drug-resistant tuberculosis that have been documented in different countries and regions and implemented by different stakeholders. Case studies presented in the document are lessons learned for scale-up of public-private mix for the management of drug-resistant TB at country level.
This infographic provides a variety of information regarding latent TB infection in the United States, including the estimated number of people with latent TB infection, the cost-effectiveness of latent TB infection treatment, and who should be tested. Supporting graphics are available to use in print and online content.
